Safety Factor
i. under normal physiologic conditions, the endplate potential generated by the release of 20% of the immediate store vesicles always generate an end plate potential voltage well above ~50mV
ii. difference between the endplate potential and -50mV is known as the safety factor for NMJ transmission
iii. there is a decrease of EPP, but the decrease never falls below -50mV
Synaptobrevin
vesicle membrane protein; essential for vesicle release; binds to SNAP-25 and syntaxin on presynaptic membrane
SNAP-25 and Syntaxin
proteins on cytoplasmic side of presynaptic membrane; binds to Synaptobrevin; allows vesicle release
Lambert-Eaton Disease aka Lambert-Eaton Myasthenia Gravis (LEMS)
- antibodies are formed against Ca channel
primary, secondary and tertiary vesicles
acetylcholinesterase
breaks ACh into acetate and choline
Nicotinic acetylcholine receptors (adult and fetal)
fetal and adult different; need 2 ACh to bind to it in order to activate it; you can different types of antibodies depending on A or F types of receptors
MUSK (muscle specific tyrosine kinase) protein
part of ACh receptor complex; antibodies to this will fuck with the receptors
Botulism
clostridium botulinum
MOA: uses proteinases to digest synaptobrevin or SNAP25/syntaxin
Organophosphorus gases (sarin)
-react with AChE irreversibly
-activates nicotinic receptor repetitively
Significance: notable for causing spasticity at first but THEN paralysis because Na channels get inactivated (by lowering of threshold to -45mV)
Autoimmune Myasthenia Gravis
MOA: antibodies directed at AChE receptor and MuSK
Succinylcholine
post-synaptic; succinyl choline and -Paralytic used in anesthesia
Falling below safety factor
Mechanism of NMJ disease
Complete inhibition of AChE paradoxically
Leads to paralysis because of new threshold (-45mV) formed required for SODIUM channel opening on POSTsynaptic terminal
Symptoms of Lambert Eaton
Symptoms of Botulism
Weakness in face that then descends to limbs and respiratory muscles; common in infants; treated with botulinum immunoglobulin (BIG)
Tetanus
Physostigmine, Neostigmine, Pyridostimine
Symptoms of Autoimmune Myasthenia Gravis
Partial inhibition of AChE
used therapeutically to treat NMJ impairment